Electroconvulsive therapy (ECT) is a treatment for certain mental illnesses. During this therapy, electrical currents are sent through the brain to induce a seizure.
The procedure has been shown to help people with clinical depression. It’s most often used to treat people who don’t respond to medication.
Electroconvulsive therapy (ECT) is a treatment for certain mental illnesses. During this therapy, electrical currents are sent through the brain to induce a seizure.
The procedure has been shown to help people with clinical depression. It’s most often used to treat people who don’t respond to medication.
Electroconvulsive Therapy is still being used. It is a procedure usually done under general anesthesia, in which small electric currents are passed through the brain, intentionally triggering a brief seizure.
obsessive compulsive and related disorders (OCD)mamtabisht10
Obsessive-Compulsive and related disorders include obsessive-compulsive disorder (OCD), body dysmorphic disorder, hoarding disorder, trichotillomania (hair-pulling disorder), and excoriation (skin-picking) disorder.
It describes the commonly used terminology in mental health nursing.It forms the basic concept in the mind of students related to psychiatric nursing and psychology.
hii guys this is my ongoing presentation from my speciality class i hope u guys lije that please so i hope it is been useful for u in ur specialities by getting little help with that
This slide contains information regarding Electro Convulsive Therapy. This can be helpful for proficiency level and bachelor level nursing students. Your feedback is highly appreciated. Thank you!
Electroconvulsive Therapy is still being used. It is a procedure usually done under general anesthesia, in which small electric currents are passed through the brain, intentionally triggering a brief seizure.
obsessive compulsive and related disorders (OCD)mamtabisht10
Obsessive-Compulsive and related disorders include obsessive-compulsive disorder (OCD), body dysmorphic disorder, hoarding disorder, trichotillomania (hair-pulling disorder), and excoriation (skin-picking) disorder.
It describes the commonly used terminology in mental health nursing.It forms the basic concept in the mind of students related to psychiatric nursing and psychology.
hii guys this is my ongoing presentation from my speciality class i hope u guys lije that please so i hope it is been useful for u in ur specialities by getting little help with that
This slide contains information regarding Electro Convulsive Therapy. This can be helpful for proficiency level and bachelor level nursing students. Your feedback is highly appreciated. Thank you!
ECT is a somatic therapy where electrical stimulation is given to the brain to induce grandmal seizures. It is used to treat psychotic features where pharmocotherapy found ineffective or contraindicated.
Electroconvulsive therapy (ECT) is a procedure, done under general anesthesia, in which small electric currents are passed through the brain, intentionally triggering a brief seizure. ECT seems to cause changes in brain chemistry that can quickly reverse symptoms of certain mental health conditions.
Electro Convulsive Therapy & Role of nurseNeha Bhatt
Whether you're a student of mental health nursing, or conducting research or a healthcare professional seeking to deepen your understanding of ECT, this guide is your go-to resource. Gain insight into the science behind ECT and its role in contemporary psychiatric practice.
information regarding psychopharmacology especially for nursing students and community. covers all group like anti psychotic, anti anxiety, antidepressants, mood stabilizing agents etc.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
2. Definition
•Electro convulsive therapy is the induction of Grand-mal seizure through the
application of electrical current to the brain.
•An electric current is applied for a fraction of a second through electrodes
placed on the temporal region. This immediately produces two stage seizure or
convulsion (tonic and clonic stage).
ELECTROCONVULSIVETHERAPY
3. History
•ECT is a type of Somatic or physical therapy, first introduced by Ugo Cerletti,
Lucio Bini in 1938.
•Some of the other shock therapy were used earlier prior to ECT were as follows:
•Convulsive therapy was introduced in 1934 by Hungarian neuropsychiatrist
Ladislas Von Medusa induced seizures with first camphor and then metrazol
(cardiazol).
•Insulin shock therapy was introduced in 1927 by Austrian-American
psychiatrist Manfred Sakel
ELECTROCONVULSIVETHERAPY
4. METHODS OF GIVING ECT
•ECT can be given by-
•Direct method
•Indirect method
ELECTROCONVULSIVETHERAPY
5. METHODS OF GIVING ECT
Direct method (Unmodified)
•The patient is administered atropine sulphate subcutaneously 0.6 mgm to 1.0
mgm, half an hour before the treatment or IV immediately before the treatment.
•Minor tranquilizer is also used.
•A Grand-mal seizure is induced in the patient by passing an electric current
through the temporal lobe.
•Atropine reduces vomiting.
•Immediately after the ECT treatment appropriate resuscitative and other
emergency management equipments and supplies are kept ready.
ELECTROCONVULSIVETHERAPY
6. METHODS OF GIVING ECT
Indirect method (Modified)
•Electroconvulsive therapy is modified with the use anesthesia, muscle
relaxants and oxygenation.
•This method of giving ECT is also known as indirect method.
•The use of anesthesia is necessary to alloy anxiety and achieve the maximum
effect.
•It is used to modify the force of convulsion and to avoid the complications like
fractures.
•Modified ECT is also used for the patients who are recovering from heart
condition.
ELECTROCONVULSIVETHERAPY
7. Drugs used during ECT
•Atropine Sulphate- 0.6 to 1.0 mgm to control salivation and vomiting
•Minor tranquilizer
•Ultra short acting depolarizing agent (muscle relaxant) succinylcholine 0.3ml to
0.5ml.
•A short acting barbiturate, methohexial sodium (Brevital sodium) or thiopental
(Pentothal) 5ml to 10 ml.
•Oxygen
ELECTROCONVULSIVETHERAPY
9. AMOUNT OF CURRENT
•The nature and range of stimulus intensity setting varies from device to device.
• 70-120 volt for 0.7 to 1.5 second will produce a convulsive effect.
•The actual amount of current passed during the treatment was found to range
between 200-1600 milliampheres.
ELECTROCONVULSIVETHERAPY
10. OBSERVATION OF PRODUCTION OF SEIZURE
• The production of Grandmal seizure is necessary for direct and indirect or
modified ECT.
•In direct ECT, the tonic phase that is muscle contraction last for 10 seconds
approximately.
•The clonic phase that is movement or convulsion last for 25 to 30 second.
•Then the patient goes in to relaxation phase.
•With the use of anesthesia in modified ECT, mild grimace or blephro-spasm, a
tonic spasm of the eyelid muscles, is observed when the current is applied.
• There is a slow plantar flexion during the tonic phase and fine movements of
the toes during the clonic phase.
ELECTROCONVULSIVETHERAPY
11. NUMBER AND FRQUENCY OF ECT TREATMENT
• There is no clinical justification for a fixed number of treatments, however,
patient with depression shows some sort of improvement after the first few
treatments.
•Response, from the patients with bipolar disorder, mania, schizoaffective
disorder or catatonic schizophrenia, is attained between 5 to 10 treatments.
•20-25 treatments may be required for chronically ill schizophrenic patients.
ELECTROCONVULSIVETHERAPY
12. Mechanism of Action
• The exact mechanism by which ECT affect a therapeutic response is unknown.
• Several theories exist, but the one to which the most credibility has been given
is the biochemical theory.
•A number of researchers have demonstrated that electric stimulation results in
significant increases in the circulating levels of several neurotransmitters.
These neurotransmitters include serotonin, norepinephrine, and dopamine, the
same biogenic amines that are affected by antidepressant drugs.
•Additional evidence suggests that ECT may also result in increases in
glutamate and gamma amino butyric acid (GABA).
•Other theories regarding ECT are tabulated as follows:-
ELECTROCONVULSIVETHERAPY
13. Mechanism of Action
ELECTROCONVULSIVETHERAPY
S.N. OBSERVED CHANGES SIGNIFICANCE
1
EEG CHANGES
Electrocerebral silence Defibrillator like effect i.e. healthy
functioning resumes after ECT
2
NEUROCHEMICAL CHANGES
Increased GABA
Increased CSF concentration of acetyl choline and down regulation of
cortical muscarinic receptors
Causes elevated seizure threshold level;
anticonvulsant action reduces kindling
in limbic structure
May be partially responsible for memory
impairment
3
NEUROENDOCRINE CHANGES
ECT causes release of hypothalamic and pituitary hormones,
including prolactin
Release of an antidepressant hormone
from the hypothalamus
4
BLOOD-BRAIN BARRIER CHANGES
Increased cerebral blood flow and blood-brain barrier permeability May facilitate entry of the co-
administered psychotropic drugs
14. ELECTROCONVULSIVETHERAPY
Indications
•Major depressive episodes is a
primary indication
•Involutional melancholia
•Psychotic depression
•Unipolar bipolar depression
•Depression of old age
•Post partum depression
•Mania
•Catatonia
•Schizophrenia when not
responding to other therapies
•Other responsive groups to ECT
treatment are patient with-
•Premorbid personality
•Stupor
•Previous depressive episode
•Paranoid delusion
•Anorexia
•Early morning insomnia
•Weight loss
•Lack of concentration
•Ideas of guilt and worthlessness
•Suicidal thought and suicidal attempts
15. Contraindications
• Absolute contraindication for ECT-
patient with increased intracranial pressure, including tumors, hematomas, and
subarachnoid hemorrhage because these may lead to neurological deterioration
with ECT.
• Relative contraindication-
Cerebral aneurysm
Acute myocardial Infarction
Congestive heart failure
Pneumonia or aortic aneurysm
Retinal detachment
ELECTROCONVULSIVETHERAPY
16. COMPLICATION AND ADVERSE EFFECTS
•Temporary memory loss
•Fracture and dislocation
•Other complaints of patients due to ECT
Headache, backache, apnea, painful mastication, injury to the mouth and
tongue.
Stuns or subshock occur due to an insufficient current applied to the patient
which does not lead to a full convulsion stage.
It sometimes produces cardiac irregularities, respiratory distress and collapse.
Confusion after subshock is more marked than a major fit due to ECT.
If three subshock given in a day, the treatment should be stopped.
The next day ECT may be given with increased intensity of the current
ELECTROCONVULSIVETHERAPY
17. ARTICLES NEEDED FOR ECT:
Articles for the preparation of the patient:
•Pillows to put under the patient’s waist to prevent injury
•Mouth gag to prevent tongue bite and for patent airway
•Endotracheal tube and sterile suction catheter for suction of the respiratory tract
•O2 cylinder and AMBU bag for artificial respiration
Articles for the procedure:
•A trolley with an ECT machine in working order
•Jelly or normal saline for putting on electrodes as normal saline is good conductor of
electricity
•Emergency drugs and resuscitation tray
•BP apparatus, mouth wipe sterile syringes and spirit swabs.
ELECTROCONVULSIVETHERAPY
19. Role of Nurse
•Pretreatment nursing care
•Nursing care during the procedure
•Post treatment nursing care
ELECTROCONVULSIVETHERAPY
20. Role of Nurse
•Pretreatment nursing care
Obtain a written consent from the close relative after explaining the method of treatment and
risks for legal protection and as it prevents the fear of therapy.
Check that a thorough physical examination is completed including Hb estimation, ECG,
respiratory status etc.
Involve the family in the therapy as much as possible to reduce misconception and anxiety.
Communicate positive feelings about the procedure to the family and patient.
The patient should be kept NPO before treatment.
Remove lipsticks, nail polish and any other makeup prior to treatment to check for any
cyanosis.
Remove dentures or any other metallic jewelry before ECT.
Discourage cigarette smoking before procedure as it increases pulmonary secretion.
Instruct the patient to evacuate the bowel and bladder prior to ECT.
Ask the patient to not to oil the hair prior to ECT
Encourage the patient to maintain the personal hygiene.
Make sure that oxygen, Endotracheal tube, suction is accessible and in functioning condition.
Give premedication to the patient i.e. Inj atropine and Calmpose.
ELECTROCONVULSIVETHERAPY
21. Role of Nurse
•Nursing care during the procedure
Nurse should help in the transfer of the patient from trolley to the low level bed.
Place the patient in supine position and place a small pillow under the lumbar curve to prevent
injury.
Give a short acting anesthetic agent. Thiopental 0.25gm to 0.5gm IV, and succinylcholine 0.30mgm
to 0.50mgm.dose may vary patient to patient.
Place a well padded mouth gag in mouth or tongue depressor in between the teeth to prevent the
tongue bite during the seizure produced by the ECT.
Apply a light restrain on arms and shoulder to prevent the dislocation.
Hyperextend the head with support to the chin to prevent the jaw dislocation and for patent
airway.
Give a few breath of oxygen to the patient to help the patient to overcome a phase of apnea faster
after convulsion.
Provide electrodes dipped in saline or with application of jelly for placing on the temporal region.
Make an observation of grand mal seizure. The presence of the initial tonic phase last for 10-15
seconds followed by convulsion lasting for 25-30 seconds. Then there is a phase of muscular
relaxation with Sertorius respiration.
Do suction immediately to keep patent airway and prevent the patient from aspiration pneumonia.
Restore oxygen by giving o2 by mask, if required.
ELECTROCONVULSIVETHERAPY
22. Role of Nurse
•Post treatment nursing care
Observe and record respiration, pulse and blood pressure of the patient to prevent
any respiratory and cardiac complication.
Put the railings and place the patient in side lying position, wipe the secretion.
Transfer the patient to the recovery room only if can answer the simple questions like
“what is your name, lift the hands up etc.” it ensures that patient has come out of the
phase of unconsciousness.
Record TPR and BP and the level of consciousness every 15 minute to make early
nursing diagnosis of the patient going into complication.
Allow the patient to sleep for at least half an hour to one hour to get relief from
physical exhaustion.
Reorient the patient for time, place and person to avoid the confusional status.
Reassure the patient to overcome his maladaptive behavior because research stated
that post ECT patient becomes highly suggestible.
Allow the patient to take clear liquid followed by breakfast if patient does not vomit.
Encourage the patient to carry out his daily activities of living.
Make observation of any changes.
ELECTROCONVULSIVETHERAPY